Register for our daily email updates
Get the latest report summaries of more than 400 companies, plus access to the latest Edison TV interviews, invitations and exclusive events.
Cannabinoids and biosynthesis – what next?
Hot on the heels of our research analysts’ report on the fast-growing global demand for high-quality cannabinoids, we present our first Open Forum: Cannabinoids and biosynthesis – what next? Join us for exclusive insights from some of the brightest names in cannabinoids and CBD.
Recent insights and interviews from EdisonTV
Register for our weekly email updates
Get the latest report summaries of more than 400 companies, plus access to the latest Edison TV interviews, invitations and exclusive events.
Sign up today
Kind words from our clients
In an increasingly crowded market for investment products and companies, strong research that explains a trust’s underlying philosophy and key strengths plays an important role in building awareness among private wealth managers. Edison’s focus, which is on distributing research to this group, is a natural fit for quoted investment funds.
The Edison IR team has been supporting us in a very effective way since August 2017. Their investor network, specifically targeting smaller to midsize institutional investors as well as family offices, seems to be widespread. The smart leveraging of the research for the benefit of the IR, thereby both informing the IR team and investors, is very helpful. The team engagement they have shown us is impressive and much appreciated. Visibility and a hard-working spirit is a key way for companies to portray themselves – Edison applies the same principals.
Edison’s research has proven invaluable in explaining Tungsten’s business model and management’s transformation programme. The analysts there have taken the time to understand the details that have contributed to our profitability. Moreover, Edison’s distribution to a global audience has tangibly increased awareness of the company and its investment case.
